Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
28 participants
INTERVENTIONAL
2014-05-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Eating vs Skipping Breakfast on Postprandial Hyperglycemia After Lunch and Dinner in T2D
NCT02287103
Intensive Versus Conventional Hyperglycemic Control in Hospitalized Non-critically Ill Patients
NCT03510078
Breakfast Nutrition and Inpatient Glycemia
NCT01805414
In-Hospital Hyperglycemia: Effects of Treatment on Glycemic Control and Clinical Outcome
NCT00302874
Effect of Fasting on Insulin-induced Hypoglycemia Counterregulation in Healthy Humans
NCT04392843
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
YesB
On YesB day the patients will consume breakfast , lunch and dinner
Breakfast eating (YesB)
On YesB day the patients will eat Breakfast at 8:00, Lunch at 13:30 and Dinner at 19:00
Breakfast skipping (NoB)
On NoB day the patients will fast until lunch, then will eat Lunch at 13:30 and Dinner at 19:00
NoB
On NoB Day The patient will consume only lunch and dinner
Breakfast eating (YesB)
On YesB day the patients will eat Breakfast at 8:00, Lunch at 13:30 and Dinner at 19:00
Breakfast skipping (NoB)
On NoB day the patients will fast until lunch, then will eat Lunch at 13:30 and Dinner at 19:00
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Breakfast eating (YesB)
On YesB day the patients will eat Breakfast at 8:00, Lunch at 13:30 and Dinner at 19:00
Breakfast skipping (NoB)
On NoB day the patients will fast until lunch, then will eat Lunch at 13:30 and Dinner at 19:00
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HbA1c \> 7 %
* T2D since \< 10 yrs,
* . Only non treated or treated with oral antidiabetic drugs
* Those treated with insulin or GLP-1 analogs will be excluded.
Exclusion Criteria
* Serum creatinine level \> 1.5 mg/dl
* Pulmonary disease, psychiatric, immunological, neoplastic diseases or severe diabetic complications,such as cardiovascular disease, cerebrovascular disease, proliferative diabetic retinopathy, gastroparesis or anemia (Hg \> 10g/dL) or underwent bariatric surgery.
* Abnormal liver function tests
* Participating in dietary program or using of weight-loss medications
* History (within one year) of illicit drug abuse or alcoholism.
* Use of psychotropic or anoretic medication during the month immediately prior to study onset
30 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel Aviv University
OTHER
Hospital de Clinicas Caracas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniela Jakubowicz, MD
Prof. Daniela Jakubowicz MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniela Jakubowicz, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital de Clinicas Caracas
Daniela Jakubowicz, MD
Role: PRINCIPAL_INVESTIGATOR
E. Wolfson Medical Center. Israel
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HCCBI 057-2013-254
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.